Anxiety disorders and drug dependence: Evidence on sequence and specificity among adults

Psychiatry and Clinical Neurosciences

Volumn 67, Issue 3, 2013, Pages 167-173

  Goodwin, Renee D ^a,b   Stein, Dan J ^c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b Department of Medicine   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

anxiety disorders; comorbidity; depression; epidemiology; substance related disorders

Indexed keywords

ADOLESCENT; ADULT; AGORAPHOBIA; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; COMORBIDITY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG DEPENDENCE; GENERALIZED ANXIETY DISORDER; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PANIC; POSTTRAUMATIC STRESS DISORDER; SEX; SOCIAL PHOBIA; SUBSTANCE ABUSE; UNITED STATES;

ADOLESCENT; ADULT; ALCOHOLISM; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84876268516     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12030     Document Type: Article

References (40)

1. de Graaf R, Bijl RV, Spijker J, Beekman AT, Vollebergh WA,. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Soc. Psychiatry Psychiatr. Epidemiol. 2003; 38: 1-11.
2. Stinson FS, Grant BF, Dawson DA, Ruan WJ, Huang B, Saha T,. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2005; 80: 105-116.
3. Degenhardt L, Bucello C, Calabria B, et al. What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend. 2011; 117: 85-101.
4. Degenhardt L, Hall W,. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379: 55-70.
5. Dawson DA, Grant BF, Stinson FS, Chou PS,. Psychopathology associated with drinking and alcohol use disorders in the college and general adult populations. Drug Alcohol Depend. 2005; 77: 139-150.
6. Grant BF, Stinson FS, Dawson DA, Chou SP, Ruan WJ,. Co-occurrence of DSM-IV personality disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Compr. Psychiatry 2005; 46: 1-5.
7. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC,. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the national comorbidity survey. Arch. Gen. Psychiatry 1997; 54: 313-321.
8. Compton WM, Conway KP, Stinson FS, Colliver JD, Grant BF,. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. J. Clin. Psychiatry 2005; 66: 677-685.
9. Kessler RC, Adler LA, Barkley R, et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: Results from the national comorbidity survey replication. Biol. Psychiatry 2005; 57: 1442-1451.
10. Strakowski SM, DelBello MP, Fleck DE, et al. Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania. Arch. Gen. Psychiatry 2005; 62: 851-858.
11. Wiesner M, Kim HK, Capaldi DM,. Developmental trajectories of offending: Validation and prediction to young adult alcohol use, drug use, and depressive symptoms. Dev. Psychopathol. 2005; 17: 251-270.
12. Fu Q, Heath AC, Bucholz KK, et al. Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: Contribution of antisocial personality disorder in men. Arch. Gen. Psychiatry 2002; 59: 1125-1132.
13. Houston RJ, Bauer LO, Hesselbrock VM,. Depression and familial risk for substance dependence: A P300 study of young women. Psychiatry Res. 2003; 124: 49-62.
14. Lieb R, Merikangas KR, Hofler M, Pfister H, Isensee B, Wittchen HU,. Parental alcohol use disorders and alcohol use and disorders in offspring: A community study. Psychol. Med. 2002; 32: 63-78.
15. Nurnberger JI, Jr, Wiegand R, Bucholz K, et al. A family study of alcohol dependence: Coaggregation of multiple disorders in relatives of alcohol-dependent probands. Arch. Gen. Psychiatry 2004; 61: 1246-1256.
16. Bailey JA, McCloskey LA,. Pathways to adolescent substance use among sexually abused girls. J. Abnorm. Child Psychol. 2005; 33: 39-53.
17. DuBois DL, Silverthorn N,. Do deviant peer associations mediate the contributions of self-esteem to problem behavior during early adolescence? A 2-year longitudinal study. J. Clin. Child Adolesc. Psychol. 2004; 33: 382-388.
18. Li F, Barrera M, Jr, Hops H, Fisher KJ,. The longitudinal influence of peers on the development of alcohol use in late adolescence: A growth mixture analysis. J. Behav. Med. 2002; 25: 293-315.
19. Merikangas KR, Stolar M, Stevens DE, et al. Familial transmission of substance use disorders. Arch. Gen. Psychiatry 1998; 55: 973-979.
20. Compton WM, Thomas YF, Conway KP, Colliver JD,. Developments in the epidemiology of drug use and drug use disorders. Am. J. Psychiatry 2005; 162: 1494-1502.
21. Henquet C, Murray R, Linszen D, van, Os J,. The environment and schizophrenia: The role of cannabis use. Schizophr. Bull. 2005; 31: 608-612.
22. Windle M, Wiesner M,. Trajectories of marijuana use from adolescence to young adulthood: Predictors and outcomes. Dev. Psychopathol. 2004; 16: 1007-1027.
23. Goodwin RD, Fergusson DM, Horwood LJ,. Association between anxiety disorders and substance use disorders among young persons: Results of a 21-year longitudinal study. J. Psychiatr. Res. 2004; 38: 295-304.
24. Johnson JG, Cohen P, Pine DS, Klein DF, Kasen S, Brook JS,. Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. JAMA 2000; 284: 2348-2351.
25. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994; 51: 8-19.
26. Kessler RC, Little RJ, Groves RM,. Advances in strategies for minimizing and adjusting for survey nonresponse. Epidemiol. Rev. 1995; 17: 192-204.
27. Wittchen HU,. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): A critical review. J. Psychiatr. Res. 1994; 28: 57-84.
28. Blazer DG, Kessler RC, McGonagle KA, Swartz MS,. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. Am. J. Psychiatry 1994; 151: 979-986.
29. Wittchen HU, Kessler RC, Zhao S, Abelson J,. Reliability and clinical validity of UM-CIDI DSM-III-R generalized anxiety disorder. J. Psychiatr. Res. 1995; 29: 95-110.
30. Wittchen HU, Zhao S, Abelson JM, Abelson JL, Kessler RC,. Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders. Psychol. Med. 1996; 26: 1169-1177.
31. Deacon BJ, Valentiner DP,. Substance use and non-clinical panic attacks in a young adult sample. J. Subst. Abuse 2000; 11: 7-15.
32. O'Brien MS, Wu LT, Anthony JC,. Cocaine use and the occurrence of panic attacks in the community: A case-crossover approach. Subst. Use Misuse 2005; 40: 285-297.
33. Valentiner DP, Mounts NS, Deacon BJ,. Panic attacks, depression and anxiety symptoms, and substance use behaviors during late adolescence. J. Anxiety Disord. 2004; 18: 573-585.
34. Gorman JM, Kent JM, Sullivan GM, Coplan JD,. Neuroanatomical hypothesis of panic disorder, revised. Am. J. Psychiatry 2000; 157: 493-505.
35. Stein DJ, Goodman WK, Rauch SL,. The cognitive-affective neuroscience of obsessive-compulsive disorder. Curr. Psychiatry Rep. 2000; 2: 341-346.
36. Schneier FR, Liebowitz MR, Abi-Dargham A, Zea-Ponce Y, Lin SH, Laruelle M,. Low dopamine D(2) receptor binding potential in social phobia. Am. J. Psychiatry 2000; 157: 457-459.
37. Volkow ND, Fowler JS, Wang GJ, Swanson JM,. Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications. Mol. Psychiatry 2004; 9: 557-569.
38. Chartier MJ, Walker JR, Stein MB,. Considering comorbidity in social phobia. Soc. Psychiatry Psychiatr. Epidemiol. 2003; 38: 728-734.
39. Zimmermann G, Pin MA, Krenz S, et al. Prevalence of social phobia in a clinical sample of drug dependent patients. J. Affect. Disord. 2004; 83: 83-87.
40. Sonntag H, Wittchen HU, Hofler M, Kessler RC, Stein MB,. Are social fears and DSM-IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults? Eur. Psychiatry 2000; 15: 67-74.